Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.42 USD | +0.76% | -2.61% | +33.82% |
05-09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
05-08 | Revolution Medicines Q1 Net Loss Narrows | MT |